Press release
Asia-Pacific Region Witnessing Rapid Expansion in PEGylated Protein Therapeutics Market | CAGR of 6.9%
PEGylated Protein Therapeutics Market
๐๐ข๐ฆ๐ฉ๐ฅ๐ฒ ๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.alliedmarketresearch.com/request-sample/3726
Market Dynamics:
The PEGylated protein therapeutics market is experiencing rapid growth, driven by increasing demand for biologic drugs across various therapeutic areas, including oncology, autoimmune disorders, and metabolic diseases. The market is characterized by a diverse pipeline of PEGylated biologics targeting multiple disease indications. Key players in the pharmaceutical industry are investing heavily in research and development to advance PEGylation technology and expand their product portfolios. Additionally, strategic collaborations and partnerships between pharmaceutical companies and academic institutions are facilitating the development of novel PEGylated therapeutics.
Therapeutic Applications:
PEGylated protein therapeutics have demonstrated efficacy in treating a wide range of medical conditions. In oncology, PEGylated liposomal formulations of chemotherapy drugs offer improved tumor targeting and reduced systemic toxicity compared to conventional chemotherapy. Similarly, PEGylated interferon-alpha has shown promise in the treatment of viral infections and certain cancers. In autoimmune disorders such as rheumatoid arthritis and multiple sclerosis, PEGylated biologics targeting pro-inflammatory cytokines have emerged as effective disease-modifying therapies. Furthermore, PEGylation has enabled the development of long-acting versions of peptide hormones and growth factors for the treatment of metabolic disorders and hormonal deficiencies.
๐ ๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ ๐จ๐ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.alliedmarketresearch.com/purchase-enquiry/3726
๐๐บ๐ฝ๐ผ๐ฟ๐๐ฎ๐ป๐ ๐๐ฒ๐ ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐ฃ๐น๐ฎ๐๐ฒ๐ฟ๐ ๐๐ฟ๐ฒ -
โข Merck & Co., Inc. (Schering-Plough Corporation),
โข UCB S.A.,
โข Biogen Inc.,
โข Shire plc (Baxalta),
โข Horizon Pharma plc.,
โข AstraZeneca PLC,
โข Amgen Inc.,
โข Leadiant Biosciences S.p.A.,
โข Pfizer Inc.,
โข F. Hoffmann-La Roche Ltd. (Genentech, Inc.,)
PEGylation is a process of addition of active polyethylene glycol (PEG) to different forms of therapeutic proteins for chemical modification. These chemically modified therapeutic proteins are called PEGylated protein therapeutics. The chemical modification due to PEGylation results in various advantages, such as an extended half-life of a drug along with low toxicity and increased proteolytic protection, over the non-modified protein therapeutics. PEGylated protein therapeutics are used in multiple conditions such as cancer, hemophilia, rheumatoid arthritis, ankylosing spondylitis, Crohns disease, and others.
The factors that drive the growth of the global PEGylated protein therapeutics market are increase in prevalence of chronic diseases, advantages offered by PEGylation, and strong presence of pipe line drugs are. However, high cost related to drug development and launch of generics during the forecast period are expected to impede the market growth. In addition, high market potential in the untapped emerging economies and increase in adoption of PEGylated protein therapeutics are expected to provide many opportunities during the forecast period.
๐๐ฒ๐ ๐๐ถ๐ป๐ฑ๐ถ๐ป๐ด๐ ๐ผ๐ณ ๐ง๐ต๐ฒ ๐ฆ๐๐๐ฑ๐ -
โข North America occupied nearly two-thirds share of the global PEGylated protein therapeutics market in 2017
โข The cancer segment is anticipated to grow with the highest CAGR throughout the forecast period.
โข Europe is anticipated to occupy one-fifth market share of the global PEGylated protein therapeutics market by 2025.
โข Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA.
๐๐ข๐ฆ๐ฉ๐ฅ๐ฒ ๐๐ฉ๐๐๐ค ๐๐จ ๐๐ฑ๐ฉ๐๐ซ๐ญ ๐ ๐จ๐ซ ๐๐จ๐ซ๐ ๐๐ฅ๐๐ซ๐ข๐๐ข๐๐๐ญ๐ข๐จ๐ง:
https://www.alliedmarketresearch.com/connect-to-analyst/3726
๐๐ฒ๐ผ๐ด๐ฟ๐ฎ๐ฝ๐ต๐ถ๐ฐ ๐ฆ๐ฒ๐ด๐บ๐ฒ๐ป๐๐ ๐๐ผ๐๐ฒ๐ฟ๐ฒ๐ฑ ๐ถ๐ป ๐๐ต๐ฒ ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐ -
The PEGylated Protein Therapeutics Market report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.
โข North America (USA and Canada)
โข Europe (UK, Germany, France and the rest of Europe)
โข Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
โข Latin America (Brazil, Mexico, and the rest of Latin America)
โข Middle East and Africa (GCC and rest of the Middle East and Africa)
๐๐ฟ๐ฒ๐พ๐๐ฒ๐ป๐๐น๐ ๐๐๐ธ๐ฒ๐ฑ ๐ค๐๐ฒ๐๐๐ถ๐ผ๐ป๐?
Q1. What are the Key Industry Leaders opinion for the Global PEGylated Protein Therapeutics Market?
Q2. Which market holds the maximum market share of the Global PEGylated Protein Therapeutics Market?
Q3. What is the total market value of Global PEGylated Protein Therapeutics Market report?
Q4. What would be forecast period in the market report?
Q5. What is the market value of Global PEGylated Protein Therapeutics Market in 2020?
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
๐๐ฏ๐ผ๐๐ ๐จ๐ -
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Asia-Pacific Region Witnessing Rapid Expansion in PEGylated Protein Therapeutics Market | CAGR of 6.9% here
News-ID: 3422905 • Views: โฆ
More Releases from Allied Market Research
Endpoint Security Market Size Growing at 8.4% CAGR Reach USD 31.9 Billion by 203 โฆ
Allied Market Research published a new report, titled, "Endpoint Security Market Size Growing at 8.4% CAGR Reach USD 31.9 Billion by 2031." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segments, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain a thorough understanding of the industry and determineโฆ
Smart Manufacturing Market Size Growing at 13.7% CAGR Reach USD 860 Billion by 2 โฆ
Allied Market Research published a new report, titled, "Smart Manufacturing Market Size Growing at 13.7% CAGR Reach USD 860 Billion by 2031." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segments, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain a thorough understanding of the industry and determineโฆ
Data Virtualization Market Sizze Growing at 21.7% CAGR Reach USD 22.2 Billion by โฆ
According to the report published by Allied Market Research, Data Virtualization Market Sizze Growing at 21.7% CAGR Reach USD 22.2 Billion by 2031. The report provides an extensive analysis of changing market dynamics, major segments, value chain, competitive scenario, and regional landscape. This research offers valuable able guidance to leading players, investors, shareholders, and startups in devising strategies for sustainable growth and gaining a competitive edge in the market.
Driving Factorsโฆ
Europe IoT Market Growing at 19.0% CAGR Reach USD 12.30 Billion by 2031
According to the report published by Allied Market Research, Europe IoT Market Growing at 19.0% CAGR Reach USD 12.30 Billion by 2031. The report provides an extensive analysis of changing market dynamics, major segments, value chain, competitive scenario, and regional landscape. This research offers valuable able guidance to leading players, investors, shareholders, and startups in devising strategies for sustainable growth and gaining a competitive edge in the market.
The Europe IoTโฆ
More Releases for PEG
Biopharma PEG Delivers Innovative PEG Solutions for Enhanced Drug Efficacy
Watertown, MA - October 24, 2024 - Biopharma PEG is excited to announce its extensive offerings of polyethylene glycol (PEG) products, including monofunctional, homobifunctional, heterobifunctional, and multi-arm PEGs, tailored for PEGylation in biopharmaceutical applications. With over 40 PEGylated drugs approved globally, the role of PEGylation in drug development is more critical than ever.
PEGylation provides numerous advantages, such as improved solubility, enhanced stability, and increased circulation time in the bloodstream. Byโฆ
Biopharma PEG Expands Multi-Arm PEG Product Line
Biopharma PEG, a leader in PEG derivatives, is excited to announce the expansion of its high-purity Multi-Arm PEG linker product line, catering to the evolving needs of the medical and bioorganic fields. These advanced PEG linkers are available in various functional groups and molecular weights ranging from 1k to 40k, offering unmatched versatility and performance for research and development in cutting-edge medical applications.
"Biopharma PEG is committed to delivering high-purity multi-armโฆ
Biopharma PEG Supplies PEG Products Used For Infectious Disease Vaccines
As of January 1, 2023, global vaccine development includes a total of 966 vaccine candidates, of which 23% (220) are traditional inactivated or attenuated vaccines. Advances in molecular technology have facilitated the development of other platforms, such as recombinant protein vaccines, nucleic acid vaccines, and viral vector vaccines, which have further diversified global vaccine development.
Recombinant protein vaccines accounted for the largest proportion of all pipeline in development, 22% (215), dueโฆ
Biopharma PEG Supplies PEG Products For Click Chemistry Reactions
What is "click chemistry"? "Click Chemistry", this is a literary name given to this kind of reaction by the Nobel Prize winner K.Burry Sharless, when the cards are put together, "click" (click). Simply put, it is to add two structures to two molecules respectively, and these two structures can be specifically combined to synthesize the required chemical molecules. One of the most famous click-chemistry reactions is the Cu-catalyzed azide-alkyne cycloadditionโฆ
Biopharma PEG Develops PEG Linkers for Antibody Drug Conjugates
Antibody-drug conjugate (ADC) is one of the fastest growing fields in tumor therapy, which consists of monoclonal antibody (Antibody), linker (Linker) and active drug (Payload). So far, there are only 15 drugs on the market in the world. However, with the development of some perfect antibody modification techniques, advanced site-specific coupling techniques and powerful small-molecule toxins, ADC drug research has mushroomed and a large number of ADC drugs are inโฆ
Biopharma PEG Provides Multi-arm PEG Derivatives Crosslinked Into Hydrogels
Polyethylene (ethylene glycol) is a hydrophilic polymer that can have a very high water content when cross-linked into a network. Polyethylene glycol (PEG) is a suitable material for biological applications because it does not normally elicit an immune response. Since the 1970s, PEG has been used to modify therapeutic proteins and peptides in order to increase their solubility, reduce their toxicity, and prolong their cyclic half-lives. In the late 1970s,โฆ
